TIL
Price:
$21.72
Market Cap:
$141.74M
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, renal caner, and others. The company was incorporated in 2018 and is headquartered in Dallas, Texas.[Read more]
Industry
Biotechnology
IPO Date
2021-03-19
Stock Exchange
NASDAQ
Ticker
TIL
According to Instil Bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.88. This represents a change of -0.33% compared to the average of -1.89 of the last 4 quarters.
The mean historical PE Ratio of Instil Bio, Inc. over the last ten years is -125.97. The current -1.88 PE Ratio has changed 49.25% with respect to the historical average. Over the past ten years (40 quarters), TIL's PE Ratio was at its highest in in the September 2023 quarter at -0.21. The PE Ratio was at its lowest in in the March 2020 quarter at -2002.47.
Average
-125.97
Median
-14.08
Minimum
-525.25
Maximum
-0.32
Discovering the peaks and valleys of Instil Bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.32
Minimum Annual Increase = -97.40%
Minimum Annual PE Ratio = -525.25
Year | PE Ratio | Change |
---|---|---|
2023 | -0.32 | -13.15% |
2022 | -0.37 | -97.40% |
2021 | -14.08 | -84.33% |
2020 | -89.83 | -82.90% |
The current PE Ratio of Instil Bio, Inc. (TIL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.92
5-year avg
-125.97
10-year avg
-125.97
Instil Bio, Inc.’s PE Ratio is greater than Assembly Biosciences, Inc. (-2.32), less than Nuvation Bio Inc. (-1.37), less than Achilles Therapeutics plc (-0.59), less than NextCure, Inc. (-0.45), less than CytomX Therapeutics, Inc. (6.71), less than Spero Therapeutics, Inc. (17.03), greater than Neoleukin Therapeutics, Inc. (-5.86),
Company | PE Ratio | Market cap |
---|---|---|
-2.32 | $94.84M | |
-1.37 | $898.63M | |
-0.59 | $40.33M | |
-0.45 | $26.35M | |
6.71 | $85.30M | |
17.03 | $50.31M | |
-5.86 | $8.20M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Instil Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Instil Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Instil Bio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Instil Bio, Inc. (TIL)?
What is the highest PE Ratio for Instil Bio, Inc. (TIL)?
What is the 3-year average PE Ratio for Instil Bio, Inc. (TIL)?
What is the 5-year average PE Ratio for Instil Bio, Inc. (TIL)?
How does the current PE Ratio for Instil Bio, Inc. (TIL) compare to its historical average?